Acadia is advancing breakthroughs in neuroscience to elevate life. Since our founding, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinson’s disease psychosis and the first and only approved drug in the United States and Canada for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on Prader-Willi syndrome, Alzheimer’s disease psychosis, and multiple other programs targeting neuro-psychiatric and neuro-rare diseases. For more information, visit us at Acadia.com and follow us on LinkedIn and X. Responsible for managing key Regional and National Long Term Care (LTC) accounts (Provider Groups, LTC Pharmacy Providers, Regional Skilled Nursing Corporate Offices, Regional and National Associations, LTC accounts within Integrated Health Systems Providers) in the assigned area.